Neochem Bio Solutions reports zero investor complaints for Q2 FY27
NEOCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Neochem Bio Solutions filed its quarterly Investor Grievance Statement under SEBI Regulation 13(3) for the quarter and half year ended 30 September 2026. The report, certified by registrar MUFG Intime India, shows zero complaints pending at the start of the quarter, zero received during the quarter, zero disposed of, and zero unresolved at the end. This is a routine compliance filing confirming no investor grievances were recorded across NSE, BSE, SEBI, letters, or emails during the period.
Routine filing with no material impact. Confirms clean investor grievance record, indicating no shareholder service issues this quarter.